CHEERS Open Period 1 - All Technical Areas
The Air Force Research Laboratory, Human Effectiveness Directorate (RH) and the United States Air Force School of Aerospace Medicine (USAFSAM), is soliciting white papers (and potentially later technical and cost proposals) on the research located in the Statements of Objectives attached to the Continuing Human Enabling, Enhancing, Restoring and Sustaining (CHEERS) Multiple Authority Announcement (MAA) Opportunity FA2384-24-S-2233. Offered by Air Force -- Research Lab; applications due September 30, 2027.
Key Facts
- Funder
- Air Force -- Research Lab
- Award amount
- Not specified by funder
- Deadline
- September 30, 2027
- Geography
- United States
- Categories
- Healthcare, Arts & Culture, Research, Social Services
- Status
- Open
About This Grant
The Air Force Research Laboratory, Human Effectiveness Directorate (RH) and the United States Air Force School of Aerospace Medicine (USAFSAM), is soliciting white papers (and potentially later technical and cost proposals) on the research located in the Statements of Objectives attached to the Continuing Human Enabling, Enhancing, Restoring and Sustaining (CHEERS) Multiple Authority Announcement (MAA) Opportunity FA2384-24-S-2233. List of Attachments: 1. "Open Period Solicitation 1_BAA Amend...
Full requirements and application instructions: official listing.
Similar Open Grants
Research and Development (RAD) Directed Energy (RD) University Assistance Instruments
Air Force -- Research Lab
CHEERS Open Period 2 - All Technical Areas
Air Force -- Research Lab
Continuing Human Enabling Enhancing Restoring and Sustaining
Air Force -- Research Lab
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Defense Health Agency Contracting Activity - DHACA
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
National Institutes of Health